29 October 2019 2 Min Read
Merck lifted by soaring sales of go-to lung cancer drug
Sales of Keytruda grew 62.5% in the third quarter with its HPV vaccine Gardasil growing 26%
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In